Skip to main content

FDA Updates

Lung Cancer, FDA Updates

FDA Approves Tecentriq plus Chemotherapy for First-Line Treatment of Extensive-Stage Small-Cell Lung Cancer

Yvette Florio Lane

FDA Updates

FDA Approves Tecentriq plus Abraxane—First Immunotherapy for PD-L1– Positive Unresectable Locally Advanced or Metastatic Triple-Negative Breast Cancer

Yvette Florio Lane

FDA Updates

March 08, 2019 – FDA Approvals, News & Updates

Yvette Florio Lane

FDA Updates

FDA Approves Pembrolizumab for Treatment of Advanced Melanoma

Yvette Florio Lane

FDA Updates

FDA Approves Split-Dosing Regimen for Daratumumab in Patients with Multiple Myeloma

Yvette Florio Lane

FDA Updates

February 8, 2019 - FDA Approvals, News & Updates

Yvette Florio Lane

FDA Updates

February 1, 2019 - FDA Approvals, News & Updates

Yvette Florio Lane

FDA Updates

Government Shutdown Impacts FDA Drug Approvals

Yvette Florio Lane

FDA Updates

Braftovi Plus Mektovi a New Combination for Unresectable or Metastatic Melanoma with BRAF Mutation

FDA Updates

Lenvima Now Approved for Unresectable Hepatocellular Carcinoma

4
5
6
7
8
9
10

Page 7 of 13
Results 61 - 70 of 123